Lipoprotein (a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

F Kronenberg, S Mora, ESG Stroes… - European heart …, 2022 - academic.oup.com
This 2022 European Atherosclerosis Society lipoprotein(a) [Lp(a)] consensus statement
updates evidence for the role of Lp(a) in atherosclerotic cardiovascular disease (ASCVD) and …

Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials

SM Boekholdt, GK Hovingh, S Mora… - Journal of the American …, 2014 - jacc.org
Background : Levels of atherogenic lipoproteins achieved with statin therapy are highly
variable, but the consequence of this variability for cardiovascular disease risk is not well-…

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint …

BG Nordestgaard, A Langsted, S Mora… - European heart …, 2016 - academic.oup.com
Aims To critically evaluate the clinical implications of the use of non-fasting rather than
fasting lipid profiles and to provide guidance for the laboratory reporting of abnormal non-fasting …

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women

S Bansal, JE Buring, N Rifai, S Mora, FM Sacks… - Jama, 2007 - jamanetwork.com
ContextThe association of triglycerides with incident cardiovascular disease remains
controversial. Although triglyceride levels are typically obtained in the fasting state, postprandial …

[HTML][HTML] Vitamin D supplements and prevention of cancer and cardiovascular disease

…, IM Lee, W Christen, SS Bassuk, S Mora… - … England Journal of …, 2019 - Mass Medical Soc
Background It is unclear whether supplementation with vitamin D reduces the risk of cancer
or cardiovascular disease, and data from randomized trials are limited. Methods We …

Common variants associated with plasma triglycerides and risk for coronary artery disease

…, S Kanoni, A Ganna, J Chen, ML Buchkovich, S Mora… - Nature …, 2013 - nature.com
Triglycerides are transported in plasma by specific triglyceride-rich lipoproteins; in
epidemiological studies, increased triglyceride levels correlate with higher risk for coronary artery …

Association of LDL cholesterol, non–HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta …

SM Boekholdt, BJ Arsenault, S Mora, TR Pedersen… - Jama, 2012 - jamanetwork.com
Context The associations of low-density lipoprotein cholesterol (LDL-C), non–high-density
lipoprotein cholesterol (non–HDL-C), and apolipoprotein B (apoB) levels with the risk of …

[HTML][HTML] Marine n− 3 fatty acids and prevention of cardiovascular disease and cancer

…, IM Lee, W Christen, SS Bassuk, S Mora… - … England Journal of …, 2019 - Mass Medical Soc
Background Higher intake of marine n−3 (also called omega-3) fatty acids has been associated
with reduced risks of cardiovascular disease and cancer in several observational studies…

Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms

S Mora, N Cook, JE Buring, PM Ridker, IM Lee - Circulation, 2007 - Am Heart Assoc
… Using prospectively collected data from the Women’s Health Study with 27 055 initially
healthy women followed up for 11 years, we found that even moderate levels of physical activity (…

CAP defines a second signalling pathway required for insulin-stimulated glucose transport

…, M Kanzaki, DC Thurmond, S Mora, S Shigematsu… - Nature, 2000 - nature.com
Insulin stimulates the transport of glucose into fat and muscle cells. Although the precise
molecular mechanisms involved in this process remain uncertain, insulin initiates its actions by …